Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02955069 |
|---|---|
| Brief Title: | Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) |
| First Submitted : | November 2, 2016 |
| First Submitted that Met QC Criteria : | November 2, 2016 |
| First Posted : | November 4, 2016 (Estimate) |
| Results First Submitted : | March 16, 2021 |
| Results First Submitted that Met QC Criteria : | March 16, 2021 |
| Results First Posted : | April 12, 2021 |
| Certification/Extension First Submitted : | March 19, 2019 |
| Certification/Extension First Submitted that Met QC Criteria : | April 15, 2019 |
| Certification/Extension First Posted : | April 22, 2019 |
| Last Update Submitted that Met QC Criteria : | March 16, 2021 |
| Last Update Posted : | April 12, 2021 |